Get the Stockscreener App
123.54
24.78%
24.53
Illumina Inc stock is traded at $123.54, with a volume of 6.79M.
It is up +24.78% in the last 24 hours and up +30.08% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$99.01
Open:
$106.91
24h Volume:
6.79M
Relative Volume:
3.95
Market Cap:
$18.99B
Revenue:
$4.28B
Net Income/Loss:
$1.26B
P/E Ratio:
15.65
EPS:
7.8957
Net Cash Flow:
$943.00M
1W Performance:
+23.40%
1M Performance:
+30.08%
6M Performance:
+59.20%
1Y Performance:
-14.29%
1-Day Range:
$106.12
$123.93
1-Week Range:
$94.00
$123.93
52-Week Range:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
123.54 | 15.22B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
Jennison Associates LLC Lowers Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Stake Raised by Wealthfront Advisers LLC - MarketBeat
Oppenheimer Asset Management Inc. Has $965,000 Holdings in Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. stock remain a Wall Street favorite2025 Momentum Check & Reliable Intraday Trade Plans - newser.com
Illumina, Inc. (NASDAQ:ILMN) Q3 2025 Earnings Call Transcript - Insider Monkey
Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
JPMorgan Chase & Co. Increases Illumina (NASDAQ:ILMN) Price Target to $105.00 - MarketBeat
Illumina (ILMN) Jumps 24.8% on Earnings Beat - Insider Monkey
What moving averages say about Illumina Inc.July 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com
Should I buy Illumina Inc. (ILU) stock before earnings season2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com
Illumina (NASDAQ:ILMN) Shares Gap Up After Earnings Beat - MarketBeat
Combining machine learning predictions for Illumina Inc.July 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Illumina (NASDAQ:ILMN) Given New $142.00 Price Target at Evercore ISI - MarketBeat
Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
What momentum indicators show for Illumina Inc. stockFed Meeting & Real-Time Buy Signal Alerts - newser.com
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Is Illumina Inc. stock safe for conservative investorsPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com
4,386 Shares in Illumina, Inc. $ILMN Acquired by Earned Wealth Advisors LLC - MarketBeat
Why Illumina Inc. (ILU) stock benefits from AI revolutionJuly 2025 Decliners & Consistent Return Strategy Ideas - newser.com
Illumina (ILMN) Returns to Profitability, Undervalued Versus Peers but Growth Lags Market - Yahoo Finance
Illumina, Inc. $ILMN Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Keybank National Association OH Decreases Position in Illumina, Inc. $ILMN - MarketBeat
Y Intercept Hong Kong Ltd Has $2.41 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. (ILU) stock test record highs in 2025Quarterly Trade Review & Technical Pattern Based Buy Signals - newser.com
Why Illumina Inc. stock is considered a top pickGap Down & Verified Momentum Stock Watchlist - newser.com
Analyzing Illumina Inc. with risk reward ratio chartsJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - newser.com
Can Illumina Inc. (ILU) stock surprise with quarterly resultsBreakout Watch & Free Growth Oriented Trading Recommendations - newser.com
Illumina, Inc. (ILMN) Stock Forecasts - Yahoo! Finance Canada
Illumina (NASDAQ:ILMN) Issues Earnings Results - MarketBeat
Illumina’s Strategic Moves Propel Share Price - timothysykes.com
Illumina (NASDAQ:ILMN) Releases FY 2025 Earnings Guidance - MarketBeat
Illumina Stock Soaring – What’s Next? - StocksToTrade
Illumina, Inc. (ILMN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
U.S. Indexes Closed Up Friday; Illumina Topped Leaders - Barron's
Illumina Stock Springs Back: Investment Alert? - timothysykes.com
Illumina Inc reports results for the quarter ended September 30Earnings Summary - TradingView
China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030 - GlobeNewswire Inc.
'Hopeful' We'll Find Long-term Solution On China: Illumina CEO - MarketScreener
Evercore ISI Group Maintains Illumina (ILMN) Outperform Recommendation - Nasdaq
Research Alert: CFRA Raises Rating On Shares Of Illumina, Inc. To Buy From Hold - 富途牛牛
Illumina Raises Guidance As Strong Quarter Lifts Shares - Finimize
Why Illumina (ILMN) Stock Is Up Today - Yahoo Finance
DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars - inkl
Illumina's Management Team Is Focused on Margin Expansion - Morningstar
ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance - Yahoo Finance
UBS Adjusts Illumina Price Target to $120 From $110, Maintains Neutral Rating - MarketScreener
Real time pattern detection on Illumina Inc. stockBond Market & Short-Term Trading Opportunity Alerts - newser.com
Momentum divergence signals in Illumina Inc. chart2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
Technical analysis overview for Illumina Inc. stockStop Loss & Verified Momentum Stock Watchlist - newser.com
Canaccord Genuity raises Illumina stock price target to $112 on clinical growth - Investing.com
Developing predictive dashboards with Illumina Inc. dataRate Cut & Low Risk Growth Stock Ideas - newser.com
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):